Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.
Valenta Pharm JSC
· 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
influenza
influenza, acute respiratory viral infections, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis
#1033721
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
Record
· ID 842147
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.